| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.099 | 0.04 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.095 | 0.07 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.08 | 0.09 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.068 | 0.2 |